New Oral Drug Shrinks Lung Cancers Before Surgery, Researchers Report
Wednesday, September 17, 2008 - 20:35
in Health & Medicine
Pazopanib, a new oral angiogenesis inhibitor, has demonstrated interesting activity in difficult to treat non-small-cell lung cancer, researchers report.
Read the whole article on Science Daily
More from Science Daily
Related
- Pazopanib shrinks lung cancers before surgeryWed, 17 Sep 2008, 21:37:18 EDT
- New oral angiogenesis inhibitor offers potential nontoxic therapy for a wide range of cancersTue, 1 Jul 2008, 17:15:07 EDT
- Joining forces against cancerWed, 17 Sep 2008, 21:37:16 EDT
- Drug shrinks lung cancer tumors in miceTue, 10 Nov 2009, 13:39:02 EST
- Vandetanib shows clinical benefit when combined with docetaxel for lung cancerMon, 1 Jun 2009, 9:44:28 EDT